Work

Tu1447: IZENCITINIB INDUCTION TREATMENT IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Year: 2022

Type: conference-abstract

Source: Gastroenterology

DOI: 10.1016/s0016-5085(22)62285-6

Authors: Silvio Danese, William J. Sandborn, Laurent Peyrin-Biroulet, Deanna D. Nguyen, Tadhg Guerin, Piotr Rozpondek, Ravi Ganeshappa, Vladyslav Dubovyi, David Bourdet, Brihad Abhyankar

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4282983134

Cites:

Cited by:

Related to: 10